Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation—a narrative review from EAU endourology - Scorecard - MDSpire

Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation—a narrative review from EAU endourology

  • By

  • Bogatova, Svetlana

  • Morozov, Andrey

  • Gauhar, Vineet

  • Lifshitz, David

  • Sukhanov, Roman

  • Ehrlich, Yaron

  • Asali, Murad

  • Krupinov, German

  • Golan, Shay

  • Somani, Bhaskar K.

  • Herrmann, Thomas R. W.

  • Enikeev, Dmitry

  • February 27, 2026

  • 0 min

Share

Clinical Scorecard: Addressing Clinical Failure Following Minimally Invasive Surgical Interventions for BPH: A Comparison of Repeat MIST and Traditional Resection, Enucleation, or Ablation—A Narrative Overview from EAU Endourology

At a Glance

CategoryDetail
ConditionBenign prostatic hyperplasia (BPH) causing lower urinary tract symptoms (LUTS)
Key MechanismsMinimally invasive surgical therapies (MIST) act via mechanical expansion, ischemia-induced tissue reduction, or water-based ablation to relieve prostatic obstruction
Target PopulationMen with BPH experiencing LUTS, including sexually active and frail patients
Care SettingUrological surgical care including outpatient and operative settings

Key Highlights

  • MIST techniques (PUL, iTIND, PAE, Aquablation, Rezum) offer reduced invasiveness and preservation of sexual function compared to traditional surgeries.
  • Traditional surgeries like TURP and endoscopic enucleation of the prostate (EEP) provide superior long-term urinary flow improvement and durability but with higher risk of complications such as retrograde ejaculation.
  • Retreatment strategies after MIST failure are not well defined; TURP is frequently used as a retreatment due to its proven efficacy.

Guideline-Based Recommendations

Diagnosis

  • Assess LUTS severity and impact on quality of life using validated tools such as the International Prostate Symptom Score (IPSS).
  • Evaluate patient suitability for MIST or conventional surgery considering prostate size, symptom severity, and patient comorbidities.

Management

  • Consider MIST for patients prioritizing preservation of sexual function and reduced surgical risk, especially frail or sexually active men.
  • Use TURP or EEP as first-line surgical options for durable symptom relief and in cases of MIST failure.
  • Retreatment after MIST failure may involve repeat MIST or conversion to conventional surgery, with TURP commonly employed.

Monitoring & Follow-up

  • Monitor symptom improvement and quality of life post-procedure using IPSS and patient-reported outcomes.
  • Follow-up for potential complications including urinary incontinence and ejaculatory dysfunction.
  • Long-term monitoring is essential as some MIST techniques may show slight worsening of symptoms after 5 years.

Risks

  • MIST may have inferior long-term efficacy compared to TURP or EEP.
  • Conventional surgeries carry risks of retrograde ejaculation and other complications impacting quality of life.
  • Spinal anesthesia risks in frail patients should be considered when selecting surgical modality.

Patient & Prescribing Data

Men with BPH undergoing surgical treatment for LUTS

MIST offers a safer profile with preservation of sexual function but may require retreatment; TURP and EEP provide more durable symptom relief but with higher complication rates.

Clinical Best Practices

  • Balance efficacy and safety when selecting surgical intervention for BPH, considering patient preferences and comorbidities.
  • Inform patients about the potential need for retreatment after MIST and the comparative risks and benefits of each surgical option.
  • Use TURP as a reliable retreatment option following MIST failure due to its established efficacy.
  • Consider the limited long-term data available for newer MIST techniques when counseling patients.

References

Original Source(s)

Related Content